[1] 中华传染病学会、肝病学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8∶324-329.
|
[2]骆抗先.乙型肝炎临床与活体组织病理[M].北京∶科学出版社, 2001∶81-86.
|
[3]骆抗先.乙型肝炎基础和临床[M].第二版.北京∶人民卫生出版社, 2001∶117-191.
|
[4]Chu CM, Liaw YF.Membrane staining for hepatitis B surface antigen onhepatocytes∶a sensitive and specific marker of active viral replication inhepatitis B[J].J Clin Pathol, 1995, 48∶470-473.
|
[5]Lindh M, Savage K, Rees J, et al.HBeAg immunostaining of liver tissuein various stages of chronic hepatitis B[J].Liver, 1999, 19∶294-298.
|
[6]姜湘宁, 王功遂, 尹建军.慢性乙型肝炎患者血清HbeAg和HBVD-NA水平与肝组织病理关系的探讨[J].实用肝脏杂志, 2004, 7 (2) ∶86-88.
|
[7]Chu CM, Yeh CT, Chien RN, et al.The degree of hepatocyte nuclearbut not cytoplasmic expression of hepatitis B core antigen reflect the levelof viral replication in chronic hepatitis B virus infection[J].J Clin Miro-biol, 1997, 35∶102-105.
|
[8]张宜俊, 章谷生.乙型肝炎生物治疗[M].上海∶上海科学技术出版社, 2001∶244-251.
|